University of Pittsburgh
The University of Pittsburgh conducts over $620 million in sponsored research annually, and ranks 6th in National Institutes of Health awards. This research activity generates over 200 invention disclosures on an annual basis, which are evaluated by the Office of Technology Management (OTM) in conjunction with the University Technology Transfer Committee for technical merit, market potential and patentability. Over 50 licenses or option agreements are executed yearly and 60 companies have been spun out of the university from 1996 to 2006.
The Office of Technology Management actively seeks to license the University’s IP portfolio to existing companies and also plays a founder role in the formation of new companies around platform technologies. The OTM also assists outside companies in identifying research collaborators within the University and in negotiating sponsored research agreements for such collaborations. It is in this capacity that OTM serves as “the bridge between science and business” at the University of Pittsburgh.
Innovations (371):
- Novel small molecule treatment for castration-resistant prostate cancer (27 JAN 12)
- A Technique for the Visualization and Quantification of Aqueous Humor Outflow in the Eye (19 JAN 12)
- Chemical Sensors based on Holey Graphene (13 JAN 12)
- New Flow-Stretch-Flexure Bioreactor for Mechanical Conditioning of Engineered Heart Valve Tissues (09 JAN 12)
- New Survey Tool to Measure Emergency Medical Services (EMS) Teamwork (06 JAN 12)
- Novel Immune Modulatory Agent in the Treatment of Neonatal Necrotizing Enterocolitis (NEC) and other inflammatory disorders (06 JAN 12)
- Directional Diffusion Fiber Tracking (02 DEC 11)
- Pupillary predictor of treatment outcome for affective disorders (22 NOV 11)
- Enhancing Oncolytic Virus Expression to Safely Optimize Efficacy (21 NOV 11)
- Novel Therapy for Head and Neck Cancer (22 SEP 11)
Find more innovations
